ReviewFrontiers in pharmacology2017

Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases.

Nicola Imperatore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.